MEI Pharma adopts a $100M Litecoin treasury strategy
Litecoin creator Charlie Lee joins MEI’s board
MEIP stock surged before falling back after the announcement
MEI Pharma (NASDAQ: MEIP), a biotech firm, has taken an unexpected but attention-grabbing turn by launching a $100 million Litecoin treasury strategy. This significant crypto-focused financial pivot marks one of the first major treasury moves involving Litecoin by a publicly traded U.S. company.
The initiative is backed by Titan Partners Group and crypto trading firm GSR, signaling strong institutional confidence in MEI’s new approach. In a major development, Litecoin creator Charlie Lee has joined the company’s board of directors, adding credibility and visibility to the plan. The Litecoin Foundation has also directly invested in MEI Pharma, reinforcing its commitment to expanding Litecoin’s real-world use cases.
Market Reaction: Volatile Yet Telling
News of the strategy sparked a frenzy among traders, with MEIP stock skyrocketing from $4.20 to $11.45 in a matter of hours. However, the excitement was short-lived. The price quickly corrected and settled around $6. This sharp movement reflects both optimism and uncertainty among investors reacting to MEI’s sudden alignment with the crypto world.
Despite the volatility, MEI’s leadership views this as a long-term play. The company aims to diversify its treasury while strengthening ties with the crypto ecosystem—a rare but bold move for a pharmaceutical firm.
MEI Pharma (NASDAQ: MEIP) has launched a $100 million Litecoin treasury strategy, with backing from Titan Partners Group and crypto firm GSR. Litecoin creator Charlie Lee will join MEI’s board, and the Litecoin Foundation has also invested. The stock price of MEIP surged from…
— Wu Blockchain (@WuBlockchain) July 18, 2025
What This Means for Litecoin and Crypto Adoption
This development is not just about MEI Pharma—it signals a growing willingness among traditional firms to hold crypto assets like Litecoin on their balance sheets. While Bitcoin and Ethereum have historically dominated corporate treasury strategies, MEI’s embrace of Litecoin may pave the way for similar moves across other mid-cap firms.
With the Litecoin Foundation now playing an active role in MEI’s direction and Charlie Lee contributing from the inside, this partnership could elevate Litecoin’s profile in mainstream financial circles.
Read Also :
MEI Pharma Bets Big with $100M Litecoin Treasury Move
BlockDAG Opens 8-Day Full Access Window with NO VESTING PASS as Pi Hits $3.4B & BNB Targets $1K
Bitcoin to Hit $500K by Christmas, Says Billionaire Investor
BlockDAG’s 50M Buyer Battles Heat Up! SEI Faces a Pullback & PEPE Picks Up Pace
Tom Lee Says Bitcoin’s $2 Trillion Milestone Is Here to Stay
The post MEI Pharma Bets Big with $100M Litecoin Treasury Move appeared first on CoinoMedia.
